Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Edmond Wraith

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type IIJ Edmond Wraith
The Journal of Pediatrics|February 17, 2009
Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I RegistryPamela Arn, J Edmond Wraith, Lisa Underhill
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 27, 2008
Initial report from the Hunter Outcome SurveyJ Edmond Wraith, Michael Beck, Roberto Giugliani, et al.
The Journal of Pediatrics|February 4, 2009
Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patientsRobert F Wynn, Jean Mercer, Joanne Page, et al.
Journal of Inherited Metabolic Disease|March 19, 2011
The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)Elke Miebach, Heather Church, Alan Cooper, et al.
Journal of Pediatric Surgery|March 20, 2012
High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I RegistryPamela Arn, Chester Whitley, J Edmond Wraith, et al.
The Journal of Pediatrics|March 19, 2008
Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry diseaseJ Edmond Wraith, Anna Tylki-Szymanska, Nathalie Guffon, et al.
Blood Cells, Molecules & Diseases|November 16, 2010
Potential biomarkers of osteonecrosis in Gaucher diseaseElena V Pavlova, Patrick B Deegan, Jane Tindall, et al.
Pediatrics|July 4, 2007
Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)J Edmond Wraith, Michael Beck, Roderick Lane, et al.
Journal of Inherited Metabolic Disease|June 22, 2012
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceDaniel H Wiseman, Jean Mercer, Karen Tylee, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type IIJ Edmond Wraith
The Journal of Pediatrics|February 17, 2009
Characterization of surgical procedures in patients with mucopolysaccharidosis type I: findings from the MPS I RegistryPamela Arn, J Edmond Wraith, Lisa Underhill
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 27, 2008
Initial report from the Hunter Outcome SurveyJ Edmond Wraith, Michael Beck, Roberto Giugliani, et al.
The Journal of Pediatrics|February 4, 2009
Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patientsRobert F Wynn, Jean Mercer, Joanne Page, et al.
Journal of Inherited Metabolic Disease|March 19, 2011
The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome)Elke Miebach, Heather Church, Alan Cooper, et al.
Journal of Pediatric Surgery|March 20, 2012
High rate of postoperative mortality in patients with mucopolysaccharidosis I: findings from the MPS I RegistryPamela Arn, Chester Whitley, J Edmond Wraith, et al.
The Journal of Pediatrics|March 19, 2008
Safety and efficacy of enzyme replacement therapy with agalsidase beta: an international, open-label study in pediatric patients with Fabry diseaseJ Edmond Wraith, Anna Tylki-Szymanska, Nathalie Guffon, et al.
Blood Cells, Molecules & Diseases|November 16, 2010
Potential biomarkers of osteonecrosis in Gaucher diseaseElena V Pavlova, Patrick B Deegan, Jane Tindall, et al.
Pediatrics|July 4, 2007
Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)J Edmond Wraith, Michael Beck, Roderick Lane, et al.
Journal of Inherited Metabolic Disease|June 22, 2012
Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experienceDaniel H Wiseman, Jean Mercer, Karen Tylee, et al.
Pageof 3